Ins ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today announced that it has received the first clinical milestone payment of ...
This upward trend in prescriptions and its integration into first- and second-line treatment settings for major depressive disorder highlight the drug’s growing acceptance and potential ... which ...